Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H24N4O2.2C2H6O4S |
| Molecular Weight | 592.683 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OCCS(O)(=O)=O.OCCS(O)(=O)=O.NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1
InChI
InChIKey=YBVNFKZSMZGRAD-UHFFFAOYSA-N
InChI=1S/C19H24N4O2.2C2H6O4S/c20-18(21)14-4-8-16(9-5-14)24-12-2-1-3-13-25-17-10-6-15(7-11-17)19(22)23;2*3-1-2-7(4,5)6/h4-11H,1-3,12-13H2,(H3,20,21)(H3,22,23);2*3H,1-2H2,(H,4,5,6)
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C277
Created by
admin on Fri Dec 15 15:17:47 UTC 2023 , Edited by admin on Fri Dec 15 15:17:47 UTC 2023
|
||
|
FDA ORPHAN DRUG |
1083
Created by
admin on Fri Dec 15 15:17:47 UTC 2023 , Edited by admin on Fri Dec 15 15:17:47 UTC 2023
|
||
|
WHO-ATC |
P01CX01
Created by
admin on Fri Dec 15 15:17:47 UTC 2023 , Edited by admin on Fri Dec 15 15:17:47 UTC 2023
|
||
|
FDA ORPHAN DRUG |
21187
Created by
admin on Fri Dec 15 15:17:47 UTC 2023 , Edited by admin on Fri Dec 15 15:17:47 UTC 2023
|
||
|
FDA ORPHAN DRUG |
3784
Created by
admin on Fri Dec 15 15:17:47 UTC 2023 , Edited by admin on Fri Dec 15 15:17:47 UTC 2023
|
||
|
FDA ORPHAN DRUG |
25887
Created by
admin on Fri Dec 15 15:17:47 UTC 2023 , Edited by admin on Fri Dec 15 15:17:47 UTC 2023
|
||
|
NCI_THESAURUS |
C514
Created by
admin on Fri Dec 15 15:17:47 UTC 2023 , Edited by admin on Fri Dec 15 15:17:47 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m8497
Created by
admin on Fri Dec 15 15:17:47 UTC 2023 , Edited by admin on Fri Dec 15 15:17:47 UTC 2023
|
PRIMARY | Merck Index | ||
|
7995
Created by
admin on Fri Dec 15 15:17:47 UTC 2023 , Edited by admin on Fri Dec 15 15:17:47 UTC 2023
|
PRIMARY | RxNorm | ||
|
1504900
Created by
admin on Fri Dec 15 15:17:47 UTC 2023 , Edited by admin on Fri Dec 15 15:17:47 UTC 2023
|
PRIMARY | |||
|
DTXSID5023796
Created by
admin on Fri Dec 15 15:17:47 UTC 2023 , Edited by admin on Fri Dec 15 15:17:47 UTC 2023
|
PRIMARY | |||
|
DBSALT000967
Created by
admin on Fri Dec 15 15:17:47 UTC 2023 , Edited by admin on Fri Dec 15 15:17:47 UTC 2023
|
PRIMARY | |||
|
PENTAMIDINE ISETHIONATE
Created by
admin on Fri Dec 15 15:17:47 UTC 2023 , Edited by admin on Fri Dec 15 15:17:47 UTC 2023
|
PRIMARY | Description: A white, or almost white, crystalline powder; odourless. Solubility: Soluble in 10 parts of water; slightly soluble in ethanol (~750 g/L) TS; practically insoluble in ether R. Category: Antipneumocystosis, antitoxoplasmosis and antitrypanosomal activity. Storage: Pentamidine isetionate should be kept in a well-closed container. Additional information: Pentamidine isetionate is hygroscopic and exhibits polymorphism. Definition: Pentamidine isetionate contains not less than 98.5% and not more than 102.5% of C19H24N4O2,2C2H6O4S, calculatedwith reference to the dried substance. | ||
|
100000079776
Created by
admin on Fri Dec 15 15:17:47 UTC 2023 , Edited by admin on Fri Dec 15 15:17:47 UTC 2023
|
PRIMARY | |||
|
C29349
Created by
admin on Fri Dec 15 15:17:47 UTC 2023 , Edited by admin on Fri Dec 15 15:17:47 UTC 2023
|
PRIMARY | |||
|
V2P3K60DA2
Created by
admin on Fri Dec 15 15:17:47 UTC 2023 , Edited by admin on Fri Dec 15 15:17:47 UTC 2023
|
PRIMARY | |||
|
V2P3K60DA2
Created by
admin on Fri Dec 15 15:17:47 UTC 2023 , Edited by admin on Fri Dec 15 15:17:47 UTC 2023
|
PRIMARY | |||
|
SUB14795MIG
Created by
admin on Fri Dec 15 15:17:47 UTC 2023 , Edited by admin on Fri Dec 15 15:17:47 UTC 2023
|
PRIMARY | |||
|
CHEMBL55
Created by
admin on Fri Dec 15 15:17:47 UTC 2023 , Edited by admin on Fri Dec 15 15:17:47 UTC 2023
|
PRIMARY | |||
|
620107
Created by
admin on Fri Dec 15 15:17:47 UTC 2023 , Edited by admin on Fri Dec 15 15:17:47 UTC 2023
|
PRIMARY | |||
|
TT-72
Created by
admin on Fri Dec 15 15:17:47 UTC 2023 , Edited by admin on Fri Dec 15 15:17:47 UTC 2023
|
PRIMARY | |||
|
205-424-1
Created by
admin on Fri Dec 15 15:17:47 UTC 2023 , Edited by admin on Fri Dec 15 15:17:47 UTC 2023
|
PRIMARY | |||
|
7977
Created by
admin on Fri Dec 15 15:17:47 UTC 2023 , Edited by admin on Fri Dec 15 15:17:47 UTC 2023
|
PRIMARY | |||
|
757400
Created by
admin on Fri Dec 15 15:17:47 UTC 2023 , Edited by admin on Fri Dec 15 15:17:47 UTC 2023
|
PRIMARY | |||
|
140-64-7
Created by
admin on Fri Dec 15 15:17:47 UTC 2023 , Edited by admin on Fri Dec 15 15:17:47 UTC 2023
|
PRIMARY | |||
|
8813
Created by
admin on Fri Dec 15 15:17:47 UTC 2023 , Edited by admin on Fri Dec 15 15:17:47 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD